Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) kicked off on Tuesday, up 2.09% from the previous trading day, before settling in for the closing price of $724.87.
On Tuesday, Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) was -1.21% drop from the session before settling in for the closing price of $788.00. A 52-week range
Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) kicked off on Tuesday, down -2.28% from the previous trading day, before settling in for the closing price of $762.00.
As on Thursday, Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) started slowly as it slid -2.71% to $782.51, before settling in for the price of $804.33 at
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Tuesday, plunged -0.14% from the previous trading day, before settling in for the closing price of $928.61. Within the
Witnessing the stock’s movement on the chart, on Wednesday, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had a quiet start as it plunged -2.18% to $941.39, before
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) kicked off on Friday, down -0.76% from the previous trading day, before settling in for the closing price of $998.23.
Nearly all the companies in the S&P 500 have now released their results for the third quarter, with positive surprises in terms of earnings for
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
